Aetiologies of bronchiectasis
Category | Cause/notes | Clinical phenotype | Specific treatment |
Post-infection | Viral, bacterial, fungal, mycobacteria (usually classified separately) | Past history of severe infection; classically unilobar bronchiectasis | No specific treatment |
NTM | M. avium and M. abscessus most frequent | Middle-aged or elderly; females with low BMI; middle lobe and lingual nodular bronchiectasis; cavitation; tree-in-bud | Antibiotic treatment |
Post-TB | M. tuberculosis | Upper lobe most frequently | No specific therapy |
ABPA | Hypersensitivity to A. fumigatus | History of asthma (not universal); thick sputum; S. aureus in sputum; central bronchiectasis; fleeting infiltrates | Steroids±antifungals |
COPD | Smoking, biomass exposure | Fixed airflow obstruction; smoking history; bilateral lower lobe; tubular bronchiectasis | No specific therapy |
Asthma | Not universally accepted as a cause of bronchiectasis | Long history of asthma; frequent exacerbations; neutrophilic airway inflammation | Inhaled corticosteroids, biologics e.g. anti-IgE and anti-IL5 |
Aspiration/inhalation | Foreign body aspiration, gastric contents aspiration, inhalation of corrosive substances | Lower lobe bronchiectasis | Speech and language therapy, fundoplication, removal of exacerbating drugs |
Obstruction | Benign tumours, enlarged lymph nodes | Single lobe bronchiectasis | Removal of obstruction via bronchoscopy or thoracic surgery |
Congenital defects of large airways | Marfan syndrome, Mounier-Kuhn syndrome (tracheobronchomegaly), Williams–Campbell syndrome (bronchial cartilage deficiency) | Specific features depending on the congenital defect | Dependant on the underlying disorder |
AATD | Unopposed protease activity | Combined emphysema and bronchiectasis | Augmentation therapy is available in some countries |
Yellow nail syndrome | Lymphatic obstruction | Dystrophic nails, pleural effusions, rhinosinusitis | Local treatment for nails e.g. vitamin-E, management of lymphoedema |
Immunological defects | Primary: common variable immune deficiency, agammaglobulinemia, hyper-IgE syndrome; secondary: chemotherapy, immunosuppressant therapy, malignancy, HIV/AIDS | Varied clinical pattern depending on the underlying cause; patient may give a history of non-respiratory infections | Ig replacement, prophylactic antibiotics, treatment of underlying disorder, removal of iatrogenic immunosuppression |
Young's syndrome | Cause not known | Bronchiectasis, rhinosinusitis and reduced fertility | See ciliary disorders below |
PCD | Genetic | Middle lobe and lower lobe bronchiectasis; rhinosinusitis; middle ear infections; situs inversus in some cases | Recognition and treatment of associated problems (including rhinosinusitis, middle ear disease, infertility, ectopic pregnancy), genetic counselling, intensive airway clearance |
Systemic inflammatory disease | Rheumatoid arthritis, sarcoidosis, systemic lupus erythematosus, Sjögren syndrome | Varied clinical pattern, often rapidly progressive | No specific treatment |
Inflammatory bowel disease | Ulcerative colitis, Crohn's syndrome, coeliac disease | Varied clinical pattern often high sputum volumes and steroid responsive | Inhaled and systematic corticosteroids, treatment of the underlying condition |
Adult CF | CFTR mutations | Upper lobe bronchiectasis; P. aeruginosa or S. aureus in sputum; non-respiratory manifestations | Specialist multidisciplinary care in adult CF centres, recognition and treatment of non-respiratory manifestations, CFTR modulator/corrector therapy |
Diffuse panbronchiolitis | Idiopathic inflammatory disease | Mostly patients of Far Eastern ethnic origin | Macrolide antibiotics |
NTM: nontuberculous mycobacteria; TB: tuberculosis; ABPA: allergic bronchopulmonary aspergillosis; COPD: chronic obstructive pulmonary disease; AATD: α1-antitrypsin deficiency; PCD: primary ciliary dyskinesia; CF: cystic fibrosis; M. avium: Mycobacterium avium; M. abscessus: Mycobacterium abscessus; M. tuberculosis: Mycobacterium tuberculosis; A. fumigatus: Aspergillus fumigatus; S. aureus: Staphylococcus aureus; BMI: body mass index; Ig: immunoglobulin; IL: interleukin; CFTR: cystic fibrosis transmembrane conductance regulator; P. aeruginosa: Pseudomonas aeruginosa.